Anxiety News and Research

Latest Anxiety News and Research

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.

2 Jun 2015

Key lifestyle changes could help reduce risk of cognitive decline

The evidence is mounting: People can reduce their risk of cognitive decline by making key lifestyle changes. That is the conclusion of a new research summary published online today in Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

1 Jun 2015

Connect.Parkinson national research study achieves enrollment target

The National Parkinson Foundation (NPF) announced today that the Connect.Parkinson national research study, comparing telemedicine care delivered to remote patients from a Parkinson's disease center of excellence to community-based care for Parkinson's disease, has achieved its enrollment target.

1 Jun 2015

US patients undergoing orthopaedic surgery receive more treatments for pain

New research presented at this year's Euroanaesthesia conference in Berlin shows that American patients undergoing orthopaedic surgery* receive more treatments for pain and that their experience of pain differs in some aspects to orthopaedic patients internationally.

1 Jun 2015

PEPRR intervention successfully reduces stress of cancer caregivers

Stem cell transplant is essential in the care of many blood cancers, but leaves patients requiring in-home care for months after.

30 May 2015

Larger studies needed to validate multigene testing for prediction of breast cancer risk

While advances in technology have made multigene testing, or "panel testing," for genetic mutations that increase the risk of breast or other cancers an option, authors of a review published today in the New England Journal of Medicine say larger studies are needed in order to provide reliable risk estimates for counseling these patients.

29 May 2015

New MSU research finds that use of tablets can help older adults cross the 'digital divide'

One way to help the elderly cross what's known as the "digital divide" is the use of tablets, those smaller, lighter, easy-to-use computers that seem to be taking the place of laptops.

29 May 2015

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

Some decisions arouse far more anxiety than others. Among the most anxiety-provoking are those that involve options with both positive and negative elements, such choosing to take a higher-paying job in a city far from family and friends, versus choosing to stay put with less pay.

29 May 2015

Surprising link found between creative problem-solving and increased activity in the cerebellum

Investigators at Stanford University have found a surprising link between creative problem-solving and heightened activity in the cerebellum, a structure located in the back of the brain and more typically thought of as the body's movement-coordination center.

29 May 2015

Tackling comorbidities could improve MS survival

Survival of patients with multiple sclerosis is still reduced, despite recent improvements, say researchers.

28 May 2015

Manic symptoms during depression warn of polarity switch

Concomitant manic symptoms and panic attacks are the strongest predictors of an impending switch to mania among patients with bipolar disorder who are currently depressed, shows analysis of the STEP-BD study.

27 May 2015

Addiction history indicates bipolar conversion risk from precursor disorders

Substance use and the presence of subthreshold affective symptoms may predict future bipolar disorder in young people with precursor conditions such as depression, research suggests.

27 May 2015

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Responding to rapidly shifting legal and cultural environments, researchers at the University of Montreal and CHU Sainte-Justine Children's Hospital have found a way to prevent, reduce or delay cannabis use amongst some at-risk youth. Cannabis users are at risk of neurocognitive deficits, reduced educational and occupational attainment, motor vehicle accidents, exacerbation of psychiatric symptoms, and precipitation of psychosis.

26 May 2015

Depression increases risk of mortality in patients with heart failure

Moderate to severe depression is associated with a 5-fold increased risk of all cause mortality in patients with heart failure, according to research presented today at Heart Failure 2015. The results from OPERA-HF show that risk was independent of comorbidities and severity of heart failure. Patients who were not depressed had an 80% lower mortality risk.

24 May 2015

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Today, Rhodes Pharmaceuticals L.P. announced that Aptensio XR, a once-daily central nervous system stimulant indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) will be available to patients beginning Summer 2015.

22 May 2015

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Magstim is the pioneer of TMS technology, having built a reputation for developing leading medical devices in the research field for over 25 years. ..

From Magstim 21 May 2015

Greater evidence-based help needed for depressed workers - New report from The Work Foundation

A report from Lancaster University’s Work Foundation recommends that in order to improve both productivity and health and wellbeing among those of working age, more concerted action must be taken to support people with depression to stay in and to return to work...

21 May 2015

Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Teens with slower performance on a test of "cognitive processing speed" are more likely to have depression and anxiety symptoms as adults, reports a paper in Psychosomatic Medicine: Journal of Biobehavioral Medicine, the official journal of the American Psychosomatic Society.

20 May 2015

Magstim Rapid2 Therapy System receives FDA clearance for treatment of drug resistant MDD

The Magstim Company Ltd, an innovative and award winning Wales-based medical device manufacturer, has received FDA 510(k) clearance to market its Magstim Rapid2 Therapy System for the treatment of drug resistant Major Depressive Disorder (MDD) in the United States. The clearance enables Magstim to significantly increase access to cutting-edge Repetitive Transcranial Magnetic Stimulation (rTMS) technology for patients and clinicians.

From Magstim 20 May 2015

$NIDEK announces launch of HandyRef-K / HandyRef for accurate refraction, keratometry measurements$

NIDEK announces launch of HandyRef-K / HandyRef for accurate refraction, keratometry measurements

NIDEK CO. LTD., a global leader in the design, manufacturing, and distribution of ophthalmic, optometric, and lens edging equipment, will launch the HandyRef-K / HandyRef in May 2015.

20 May 2015

Anxiety News and Research

Latest Anxiety News and Research

Upsher-Smith announces FDA approval of sNDA for Qudexy XR extended-release capsules

Key lifestyle changes could help reduce risk of cognitive decline

Connect.Parkinson national research study achieves enrollment target

US patients undergoing orthopaedic surgery receive more treatments for pain

PEPRR intervention successfully reduces stress of cancer caregivers

Larger studies needed to validate multigene testing for prediction of breast cancer risk

New MSU research finds that use of tablets can help older adults cross the 'digital divide'

MIT researchers find neural circuit that appears to cause decision-making in approach-avoidance conflict

Surprising link found between creative problem-solving and increased activity in the cerebellum

Tackling comorbidities could improve MS survival

Manic symptoms during depression warn of polarity switch

Addiction history indicates bipolar conversion risk from precursor disorders

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Depression increases risk of mortality in patients with heart failure

Aptensio XR once-daily treatment for ADHD to be available in Summer 2015

Magstim Announces FDA (510k) Clearance of rTMS (repetitive Transcranial Magnetic Stimulation) Therapy System

Greater evidence-based help needed for depressed workers - New report from The Work Foundation

Teens with slower cognitive processing speed experience depression, anxiety symptoms as adults

Magstim Rapid2 Therapy System receives FDA clearance for treatment of drug resistant MDD

NIDEK announces launch of HandyRef-K / HandyRef for accurate refraction, keratometry measurements

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Anxiety News and Research

Latest Anxiety News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in